Crown Bioscience | Medicines Discovery Catapult
Crown Bioscience, a CRO specializing in oncology and immuno-oncology, offers preclinical research, translational platforms, and clinical trial support to biotech and pharmaceutical companies to drive drug development and discovery. It provides unique tumor organoid models and the world’s largest commercially available PDX collection, along with advanced laboratory services and an extensive biobank of liquid and human biospecimens across 11 global facilities.
Medicines Discovery Catapult is a life science innovation service that accelerates drug development through world-class radiochemistry, translational imaging, and integrated drug discovery services. Its radiopharmaceutical platform provides access to alpha and beta-emitting isotopes with tailored radiolabeling, PET/CT, SPECT imaging, gamma counting, biodistribution analysis, and dosimetry using OLINDA software.
